As the CEO of P&G Health Care, Paul Gama plays a pivotal role in driving strategies for the company’s Personal Health Care and Oral Care businesses. This includes iconic brands such as Vicks, Crest, and Oral-B, along with well-known brands like Metamucil, Pepto-Bismol, Fixodent, and Neurobion. P&G’s global Health Care business makes up 14% of the company's net sales. Consumer Health is among the largest industries in which P&G competes, with retail sales exceeding $375 billion and growing consumer interest in self-care and wellness.
Paul is one of P&G’s most experienced leaders in health care. With over 30 years in the industry, he has driven market-leading results and strong year-on-year innovation plans, underpinned by a keen focus on consumer needs. Paul joined P&G in 2017, bringing unmatched experience from roles at Bayer, Novartis, and Reckitt Benckiser.
Paul Gama embodies an entrepreneurial mindset that fosters a culture of ownership, accountability, and innovation within P&G Health Care. He empowers his team to make decisions, obsess over cost efficiency, and challenge the status quo, ensuring a deep commitment to driving growth and value creation. Under his leadership, the organization is inspired to embrace risks, celebrate successes, and learn from failures, all while prioritizing the consumer's needs. Paul’s vision encourages continuous improvement and innovation, making every team member a steward of the brand and a catalyst for change.
Personally, Paul and his wife Laurie have two children, Carson and Brynn. In addition to spending time with his family, Paul enjoys skiing, cycling, hiking, and traveling.
What is Paul Gama's net worth?
The estimated net worth of Paul Gama is at least $7.58 million as of October 5th, 2026. Mr. Gama owns 51,124 shares of Procter & Gamble stock worth more than $7,583,888 as of October 7th. This net worth estimate does not reflect any other assets that Mr. Gama may own. Learn More about Paul Gama's net worth.
How do I contact Paul Gama?
Has Paul Gama been buying or selling shares of Procter & Gamble?
Within the last three months, Paul Gama has sold $323,381.50 of Procter & Gamble stock. Most recently, Paul Gama sold 2,225 shares of the business's stock in a transaction on Monday, October 5th. The shares were sold at an average price of $145.34, for a transaction totalling $323,381.50. Following the completion of the sale, the chief executive officer now directly owns 51,124 shares of the company's stock, valued at $7,430,362.16. Learn More on Paul Gama's trading history.
Who are Procter & Gamble's active insiders?
Procter & Gamble's insider roster includes Victor Aguilar (Insider), Steven Bishop (CEO), Gary Coombe (CEO), Jennifer Davis (CEO), MaryLynn Ferguson-McHugh (CEO), Kathleen Fish (Insider), Ma. Francisco (CEO), Paul Gama (Chief Executive Officer, Health Care), Mary Grabowski (Insider), Michael Homan (CAO), Matthew Janzaruk (CAO), Shailesh Jejurikar (COO), R. Keith (CEO), Deborah Majoras (Insider), Jon Moeller (President, CEO & Chairman of the Board), Nelson Peltz (Director), Marc Pritchard (Insider), Balaji Purushothaman (Insider), Sundar Raman (CEO), Andre Schulten (CFO), Valarie Sheppard (VP), Carolyn Tastad (Insider), David Taylor (CEO), and Susan Whaley (CLO). Learn More on Procter & Gamble's active insiders.
Are insiders buying or selling shares of Procter & Gamble?
In the last twelve months, insiders at the sold shares 17 times. They sold a total of 364,479 shares worth more than $57,761,196.80. The most recent insider tranaction occured on October, 5th when CFO
Andre Schulten sold 3,914 shares worth more than $568,860.76. Insiders at Procter & Gamble own 0.2% of the company.
Learn More about insider trades at Procter & Gamble. Information on this page was last updated on 10/5/2026.
